News Conference News EAS 2022 FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses Michael O'Riordan May 26, 2022
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News SCAI 2022 DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year L.A. McKeown May 23, 2022
News Conference News EuroPCR 2022 Fibromuscular Dysplasia in SCAD Tied to Worse Long-term Prognosis Caitlin E. Cox May 19, 2022
News Conference News SCAI 2022 Mystery MINOCA? Many COVID STEMIs Have No Culprit Lesion L.A. McKeown May 19, 2022
News Conference News EuroPCR 2022 Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX Michael O'Riordan May 18, 2022
News Daily News Coronary Plaque Seen in Half of Asymptomatic Individuals on CTA Yael L. Maxwell May 16, 2022
News Daily News New CAC Risk Tool Helps Contextualize Scores for Younger Adults Yael L. Maxwell May 12, 2022
News Daily News Acute MI Workup in Emergency Departments Varies by Sex and Race Michael O'Riordan May 11, 2022
News Daily News Good News and Bad for High-Intensity Statin Use in ASCVD Michael O'Riordan May 05, 2022
News Daily News Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows Michael O'Riordan May 04, 2022
News Daily News PCI and CABG Are Complementary Options for Left Main CAD, Say Experts Michael O'Riordan April 27, 2022
News Daily News Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities Michael O'Riordan April 25, 2022
News Daily News Percutaneous Axillary Access: SCAI Calls for Best Practices Caitlin E. Cox April 20, 2022
News Daily News Revascularization’s Benefits in HFrEF Linked to Gains in LV Function Caitlin E. Cox April 15, 2022
News Conference News ACC 2022 No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3 Michael O'Riordan April 13, 2022
News Conference News ACC 2022 In ANOCA, Diltiazem Fails to Improve Vasomotor Function: EDIT-CMD Caitlin E. Cox April 02, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Daily News Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention Michael O'Riordan March 30, 2022